Results
|
21.
|
|
|
22.
|
|
|
23.
|
|
|
24.
|
|
|
25.
|
|
|
26.
|
|
|
27.
|
|
|
28.
|
Efficacy and safety of ataluren in patients with nonsense-mutation cystic fibrosis not receiving chronic inhaled aminoglycosides: The international, randomized, double-blind, placebo-controlled Ataluren Confirmatory Trial in Cystic Fibrosis (ACT CF). [electronic resource] by
- Konstan, M W
- VanDevanter, D R
- Rowe, S M
- Wilschanski, M
- Kerem, E
- Sermet-Gaudelus, I
- DiMango, E
- Melotti, P
- McIntosh, J
- De Boeck, K
Producer: 20210913
In:
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society vol. 19
Availability: No items available.
|
|
29.
|
|
|
30.
|
Rationalizing endpoints for prospective studies of pulmonary exacerbation treatment response in cystic fibrosis. [electronic resource] by
- VanDevanter, D R
- Heltshe, S L
- Spahr, J
- Beckett, V V
- Daines, C L
- Dasenbrook, E C
- Gibson, R L
- Raksha, Jain
- Sanders, D B
- Goss, C H
- Flume, P A
Producer: 20180523
In:
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society vol. 16
Availability: No items available.
|
|
31.
|
A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis. [electronic resource] by
- Stover, C K
- Warrener, P
- VanDevanter, D R
- Sherman, D R
- Arain, T M
- Langhorne, M H
- Anderson, S W
- Towell, J A
- Yuan, Y
- McMurray, D N
- Kreiswirth, B N
- Barry, C E
- Baker, W R
Producer: 20000731
In:
Nature vol. 405
Availability: No items available.
|